XML 106 R81.htm IDEA: XBRL DOCUMENT v3.21.2
INVESTMENTS - Recognition and Measurement of Impairment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
OTTI on Investments disclosures        
Total impairment losses recognized during the period $ 0 $ 0 $ 0 $ 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 21 30 99 101
Total impairment losses recognized in earnings 21 30 99 101
Debt securities available-for-sale (AFS)        
OTTI on Investments disclosures        
Total impairment losses recognized during the period 0 0 0 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 21 30 99 101
Total impairment losses recognized in earnings 21 30 99 101
Other assets        
OTTI on Investments disclosures        
Total impairment losses recognized during the period 0 0 0 0
Less: portion of impairment loss recognized in AOCI (before taxes) 0 0 0 0
Net impairment losses recognized in earnings for debt securities that the Company does not intend to sell nor will likely be required to sell 0 0 0 0
Impairment losses recognized in earnings for debt securities that the Company intends to sell, would more-likely-than-not be required to sell or will be subject to an issuer call deemed probable of exercise 0 0 0 0
Total impairment losses recognized in earnings $ 0 $ 0 $ 0 $ 0